We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
137 hedge funds and large institutions have $1.59B invested in Lexicon Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
41% more call options, than puts
Call options by funds: $13.2M | Put options by funds: $9.32M
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
23% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 39
21% more capital invested
Capital invested by funds: $1.31B → $1.59B (+$280M)
5% more funds holding
Funds holding: 131 → 137 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
137
Holders Change
+6
Holders Change %
+4.58%
% of All Funds
3.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
48
Reduced
39
Closed
21
Calls
$13.2M
Puts
$9.32M
Net Calls
+$3.83M
Net Calls Change
-$1.6M
Top Buyers
| 1 |
Norges Bank
Oslo,
Norway
|
+$5.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.11M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.24M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.79M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.67M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$8.83M |
| 2 |
Millennium Management
New York
|
-$8.57M |
| 3 |
RA
Royce & Associates
New York
|
-$4.07M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.97M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.36M |
